High affinity human antibodies to human nerve growth factor

Details for Australian Patent Application No. 2008287037 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Martin, Joel H.; Torres, Richard; Macdonald, Lynn; Reinhardt, Joel C.; Morra, Marc R.

Agent Watermark

Pub. Number AU-A-2008287037

PCT Pub. Number WO2009/023540

Priority 60/994,526 20.09.07 US; 61/062,860 28.01.08 US; 60/964,224 10.08.07 US; 61/079,259 09.07.08 US

Filing date 8 August 2008

Wipo publication date 19 February 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

4 March 2010 PCT application entered the National Phase

  PCT publication WO2009/023540 Priority application(s): WO2009/023540

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008287045-Cross-flow spiral heat transfer system

2008287031-A method and system for tracking and optimizing advertisements on a decentralized network